TRANSCATHETER MITRAL VALVE THERAPIES (HB 2021). Este artículo no está disponible.TRANSCATHETER MITRAL VALVE THERAPIES (HB 2021)

An essential survey of the advancing field of transcatheter mitral valve repair and replacement

Minimally invasive transcatheter therapies have revolutionized the treatment of structural heart disease. Greatly improving outcomes for higher-risk patients, transcatheter aortic valve replacement is now established as a safe and effective alternative to invasive surgery. The mitral valve, however, poses further challenges. Contending with one of the heat’s most anatomically and pathologically complex components, practitioners and engineers have yet to perfect a stream-lined, widely deliverable therapy―though they are getting closer and closer to this goal.

Transcatheter Mitral Valve Therapies provides a far-reaching survey of the field of mitral interventions in its current state. Highlighting the stumbling blocks preventing transcatheter mitral valve replacement’s widespread adoption, the book’s international group of contributors discuss the improvements to be made in repair and replacement procedures, as well as the adjunctive use of imaging and pharmacologic therapies. This ground-breaking text:

Transcatheter Mitral Valve Therapies is an important, up-to-date resource for interventional cardiologists, as well as all clinical researchers and practitioners seeking information on this vital and developing treatment.

Edited by

Ron Waksman, MD, Director of Clinical Research and Advanced Education, MedStar Cardiovascular Research Network, Cleveland Clinic, Washington, DC, USA.

Toby Rogers, MD, PhD, Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC; Cardiovascular and Pulmonary Branch, Division of Intramural Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.